Biggest risk? The current rate of growth plateaus (or a real competitor comes along) before it reaches a level of profitability sufficient to justify its current valuation. I think a few of us might have hoped for more news on the revenue front.
The current valuation dwarfs current revenue. We're all here for future growth, as soon as anything looks like derailing that I dare say it'll sink like a stone.
But nothing I've seen to date looks like doing so (to me) so I'm still here.
- Forums
- ASX - By Stock
- PNV
- 30th June 2021 Share Price Prediction
30th June 2021 Share Price Prediction, page-179
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.04 |
Change
-0.030(1.45%) |
Mkt cap ! $1.409B |
Open | High | Low | Value | Volume |
$2.09 | $2.11 | $2.03 | $1.727M | 838.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 299194 | $2.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.04 | 1559 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 294258 | 2.020 |
3 | 6246 | 2.010 |
7 | 31240 | 2.000 |
1 | 1500 | 1.995 |
2 | 2005 | 1.990 |
Price($) | Vol. | No. |
---|---|---|
2.050 | 500 | 1 |
2.070 | 25500 | 2 |
2.100 | 10972 | 2 |
2.110 | 13714 | 2 |
2.120 | 43987 | 4 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online